# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-023943
Filing Date
2018-04-30
Accepted
2018-04-30 16:57:20
Documents
6
Period of Report
2018-06-18
Effectiveness Date
2018-04-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tv491653-def14a.htm | DEF 14A | 449123
2 | GRAPHIC | lg_apollomed.jpg | GRAPHIC | 68689
3 | GRAPHIC | sg_kennethsim.jpg | GRAPHIC | 7449
4 | GRAPHIC | tv491653_meeting.jpg | GRAPHIC | 167665
5 | GRAPHIC | tv491653_pc1.jpg | GRAPHIC | 329024
6 | GRAPHIC | tv491653_pc2.jpg | GRAPHIC | 392356
| Complete submission text file | 0001144204-18-023943.txt |  | 1775191

Mailing Address 700 NORTH BRAND BLVD., SUITE 1400 GLENDALE CA 91203
Business Address 700 NORTH BRAND BLVD., SUITE 1400 GLENDALE CA 91203 818-839-5200
Apollo Medical Holdings, Inc. (Filer) CIK: 0001083446 (see all company filings)

EIN.: 870042699 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-37392 | Film No.: 18790830
SIC: 8742 Services-Management Consulting Services